216 related articles for article (PubMed ID: 17203290)
1. Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease.
Mittal RD; Manchanda PK
Immunogenetics; 2007 Feb; 59(2):159-65. PubMed ID: 17203290
[TBL] [Abstract][Full Text] [Related]
2. Role of non-HLA genetic variants in end-stage renal disease.
Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
[TBL] [Abstract][Full Text] [Related]
3. Significant association of interleukin-4 gene intron 3 VNTR polymorphism with susceptibility to knee osteoarthritis.
Yigit S; Inanir A; Tekcan A; Tural E; Ozturk GT; Kismali G; Karakus N
Gene; 2014 Mar; 537(1):6-9. PubMed ID: 24406619
[TBL] [Abstract][Full Text] [Related]
4. The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population.
Kalkan G; Karakus N; Baş Y; Takçı Z; Ozuğuz P; Ateş O; Yigit S
Gene; 2013 Sep; 527(2):565-9. PubMed ID: 23831512
[TBL] [Abstract][Full Text] [Related]
5. Association of IL-6, IL-10, and TNF-α gene polymorphism with malnutrition inflammation syndrome and survival among end stage renal disease patients.
Sharma R; Agrawal S; Saxena A; Sharma RK
J Interferon Cytokine Res; 2013 Jul; 33(7):384-91. PubMed ID: 23777202
[TBL] [Abstract][Full Text] [Related]
6. Association of variable number of tandem repeats polymorphism in the IL-4 gene with end-stage renal disease in Malaysian patients.
Vasudevan R; Norhasniza MN; Patimah I
Genet Mol Res; 2011 May; 10(2):943-7. PubMed ID: 21644211
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1beta and receptor antagonist (IL-1Ra) gene polymorphisms and the prediction of the risk of end-stage renal disease.
Manchanda PK; Kumar A; Bid HK; Mittal RD
Biomarkers; 2006; 11(2):164-73. PubMed ID: 16766392
[TBL] [Abstract][Full Text] [Related]
8. Cytokine (IL-10 -1082 and -819) and chemokine receptor (CCR2 and CCR5) gene polymorphism in North Indian patients with end-stage renal disease.
Manchanda PK; Singh R; Mittal RD
DNA Cell Biol; 2009 Apr; 28(4):177-83. PubMed ID: 19196047
[TBL] [Abstract][Full Text] [Related]
9. Association of chemokine gene variants with end stage renal disease in North Indian population.
Singh V; Jaiswal PK; Tiwari P; Kapoor R; Mittal RD
Transpl Immunol; 2013 Jun; 28(4):189-92. PubMed ID: 23615182
[TBL] [Abstract][Full Text] [Related]
10. Association between interleukin 4 gene intron 3 VNTR polymorphism and recurrent aphthous stomatitis in a cohort of Turkish patients.
Kalkan G; Yigit S; Karakus N; Baş Y; Seçkin HY
Gene; 2013 Sep; 527(1):207-10. PubMed ID: 23756192
[TBL] [Abstract][Full Text] [Related]
11. Is low-frequency distribution of TGF-beta genotype associated with increased risk for end-stage renal disease?
Mittal RD; Manchanda PK
DNA Cell Biol; 2007 Mar; 26(3):172-7. PubMed ID: 17417945
[TBL] [Abstract][Full Text] [Related]
12. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin.
Balakrishnan VS; Guo D; Rao M; Jaber BL; Tighiouart H; Freeman RL; Huang C; King AJ; Pereira BJ;
Kidney Int; 2004 Apr; 65(4):1449-60. PubMed ID: 15086488
[TBL] [Abstract][Full Text] [Related]
13. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
[TBL] [Abstract][Full Text] [Related]
14. Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India.
Manchanda PK; Kumar A; Kaul A; Mittal RD
Clin Chim Acta; 2006 Aug; 370(1-2):152-7. PubMed ID: 16545788
[TBL] [Abstract][Full Text] [Related]
15. Association of tumour necrosis factor-α polymorphism in patients with end stage renal disease.
Singh K; Prasad KN; Mishra P; Singh SK; Kharwar NK; Prasad N; Gupta A; Srivastava JK
Nephrology (Carlton); 2015 Jun; 20(6):387-91. PubMed ID: 25589331
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure.
Shu KH; Cheng CH; Wu MJ; Chen CH; Lee WC
Ren Fail; 2005; 27(1):53-7. PubMed ID: 15717635
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis.
Buraczynska M; Jozwiak L; Ksiazek P; Borowicz E; Mierzicki P
Transl Res; 2007 Aug; 150(2):101-5. PubMed ID: 17656329
[TBL] [Abstract][Full Text] [Related]
18. Association of interleukin (IL)-4 gene intron 3 VNTR polymorphism with multiple sclerosis in Turkish population.
Karakus N; Yigit S; Kurt GS; Cevik B; Demir O; Ates O
Hum Immunol; 2013 Sep; 74(9):1157-60. PubMed ID: 23756167
[TBL] [Abstract][Full Text] [Related]
19. The association of interleukin-4 haplotypes with chronic periodontitis in a Czech population.
Holla LI; Fassmann A; Augustin P; Halabala T; Znojil V; Vanek J
J Periodontol; 2008 Oct; 79(10):1927-33. PubMed ID: 18834248
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure.
Buraczynska M; Ksiazek P; Kubit P; Zaluska W
Cytokine; 2006 Nov; 36(3-4):167-72. PubMed ID: 17224277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
